• Explore /
  • Poster
  • / Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study.

Silmitasertib (CX-4945) in combination with gemcitabine and cisplatin as first-line treatment for patients with locally advanced or metastatic cholangiocarcinoma: A phase Ib/II study.

Abstract Poster

Authors

null

Mitesh J. Borad

Mayo Clinic, Scottsdale, AZ

Mitesh J. Borad , Li-Yuan Bai , Ming-Huang Chen , Joleen M. Hubbard , Kabir Mody , Sun Young Rha , Donald A. Richards , S. Lindsey Davis , John Soong , Chi-En C-E Huang , Emmett Tse , Daniel H. Ahn , Heung-Moon Chang , Chia-Jui Yen , Do-Youn Oh , Joon Oh Park , Chiun Hsu , Carlos Roberto Becerra , Jen-Shi Chen , Yen-Yang Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Hepatobiliary Cancer

Track

Hepatobiliary Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02128282

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 312)

DOI

10.1200/JCO.2021.39.3_suppl.312

Abstract #

312

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2020 Gastrointestinal Cancers Symposium

Phase II study of copanlisib in combination with gemcitabine and cisplatin in advanced cholangiocarcinoma.

Phase II study of copanlisib in combination with gemcitabine and cisplatin in advanced cholangiocarcinoma.

First Author: Elaine Tan

First Author: Yongkun Sun

First Author: Do-Youn Oh

First Author: Tanios S. Bekaii-Saab